Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group

Abstract

Hepatitis C virus (HCV) has emerged as an important etiologic agent of liver injury and failure in patients infected with human immunodeficiency virus (HIV). The prevalence and characteristics of HCV in a representative cohort of HIV-infected patients have not been described. Therefore, a representative sample of 1687 HIV-infected patients was studied; a 213-sample subcohort was selected by use of risk-based sampling from 2 large prospective US Adult AIDS Clinical Trials Group clinical trials. HCV prevalence, HCV RNA level, and genotype were determined. The weighted overall estimate of HCV prevalence in the study cohort was 16.1% (95% weighted confidence interval, 14.3%-17.8%), with significant variability depending on risk factors and HIV RNA levels. Among patients defined as being "at risk", 72.7% were HCV positive, whereas, among low-risk patients, the positivity rate was 3.5%. Genotype 1 was found in 83.3% of infected patients. Median HCV RNA level was 6.08x106 IU/mL. High virus loads and genotype 1 prevalence may be important to interferon-based antiviral response rates among coinfected patients.

Stroop performance in drug users classified by HIV and hepatitis C virus serostatus

“…Eighty to 90% of injection drug abusers are infected with HCV and 30 to 40% of HCV1 drug abusers are coinfected with HIV (Thorpe et al, 2000;Sherman et al, 2002). These findings raise the question of whether HCV and HIV exert additive effects on brain dysfunction.…”

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease

“…1,2 Thus, the prevalence of HIV patients coinfected with hepatitis C virus (HCV), hepatitis B virus (HBV), or both, who present with end-stage liver disease (ESLD) is increasing. [3][4][5] HIV coinfected patients tend to suffer from an aggressive HCV course, thus resulting in liver failure at a faster rate when compared with individuals without coinfection. 6 In addition, almost all of the antiretroviral agents used for the treatment of HIV are metabolized in the liver.…”

Hypogonadism and Associated Factors in Patients With HIV Infection Based on Total and Free Testosterone

“…According to a previous study, about one out of three participants with HIV suffer from chronic hepatitis C (23). In this study, more than two thirds of the HIV-positive men had a HCV infection.…”